Australia markets closed

FSD Pharma Inc. (HUGE.CN)

Canadian Sec - Canadian Sec Real-time price. Currency in CAD
Add to watchlist
0.4300-0.0200 (-4.44%)
At close: 03:59PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 18.19M
Enterprise value 13.88M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)91.59
Price/book (mrq)1.01
Enterprise value/revenue 124.30
Enterprise value/EBITDA -2.16

Trading information

Stock price history

Beta (5Y monthly) 0.99
52-week change 3-70.20%
S&P500 52-week change 326.36%
52-week high 32.2300
52-week low 30.3750
50-day moving average 30.7580
200-day moving average 31.2844

Share statistics

Avg vol (3-month) 357.64k
Avg vol (10-day) 354.93k
Shares outstanding 540.43M
Implied shares outstanding 640.43M
Float 834.66M
% held by insiders 116.77%
% held by institutions 13.62%
Shares short (15 Apr 2024) 45.32k
Short ratio (15 Apr 2024) 40.15
Short % of float (15 Apr 2024) 40.02%
Short % of shares outstanding (15 Apr 2024) 40.01%
Shares short (prior month 15 Mar 2024) 412.02k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:201
Last split date 316 Oct 2019

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-43.02%
Return on equity (ttm)-83.91%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -16.73M
Net income avi to common (ttm)-17.9M
Diluted EPS (ttm)-0.6300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.51M
Total cash per share (mrq)0.09
Total debt (mrq)339.2k
Total debt/equity (mrq)2.63%
Current ratio (mrq)2.43
Book value per share (mrq)0.34

Cash flow statement

Operating cash flow (ttm)-10.83M
Levered free cash flow (ttm)-15.51M